Effect of Manual Therapy on pain, functionality and health of the feet of recreational runners

Effect of Myofascial Release on pain, functionality and health of the feet of recreational runners

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

REBEC

Registry ID

RBR-7q9hnmt

Enrollment

100

Registered

2024-03-20

Start date

2022-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fascia

Interventions

This is a randomized controlled clinical trial with concealed allocation and blinded assessors. Participants were allocated to two groups. Intervention group: 50 recreational runners of both sexes wit

Eligibility

Inclusion criteria

Inclusion criteria: Presence of forefoot, midfoot, or rearfoot pain rated 3 or higher on the Visual Analog Scale; at least six months of running experience; running a minimum of 20 km per week

Exclusion criteria

Exclusion criteria: Contraindications to Manual Therapy (tumors, fractures, rheumatoid arthritis, osteoporosis, severe vascular disease, and local skin lesions); previous surgery involving the ankle or foot; diagnosis of fibromyalgia, diabetes, neuropathies, or ankylosing spondylitis; lower limb length discrepancy greater than 1 cm; forefoot, midfoot, or rearfoot pain rated less than 3 on the Visual Analog Scale; receipt of specific treatments for the ankle and foot, including Manual Therapy, shockwave therapy, acupuncture, or foot reflexology

Design outcomes

Primary

Measure	Time frame
Expected outcome 1: A reduction in forefoot, midfoot, or rearfoot pain was expected, as assessed using the Visual Analog Scale, by comparing assessments performed before the intervention, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Observed outcome 1: A significant reduction in forefoot, midfoot, or rearfoot pain was observed among participants who received myofascial release compared with the control group, as assessed using the Visual Analog Scale before the intervention, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).	—

Measure

Time frame

Expected outcome 1: A reduction in forefoot, midfoot, or rearfoot pain was expected, as assessed using the Visual Analog Scale, by comparing assessments performed before the intervention, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Observed outcome 1: A significant reduction in forefoot, midfoot, or rearfoot pain was observed among participants who received myofascial release compared with the control group, as assessed using the Visual Analog Scale before the intervention, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).

—

Secondary

Measure	Time frame
Expected outcome 3: Improvement in ankle dorsiflexion range of motion in a weight-bearing position was expected, as assessed using the Weight-Bearing Lunge Test with a digital inclinometer (Clinometer® for Android), by comparing assessments performed before the intervention, immediately after the first treatment session, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Observed outcome 3: No significant difference in ankle dorsiflexion range of motion in a weight-bearing position was observed between participants who received myofascial release and the control group, as assessed using the Weight-Bearing Lunge Test with a digital inclinometer (Clinometer® for Android), before the intervention, immediately after the first treatment session, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Expected outcome 2: Improvement in lower limb functional performance was expected, as assessed using the Single-Leg Hop Test, by comparing the single-leg horizontal jump distance, measured in centimeters (cm), before the intervention, immediately after the first treatment session, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Observed outcome 2: No significant difference in lower limb functional performance was observed between participants who received myofascial release and the control group, as assessed using the Single-Leg Hop Test, before the intervention, immediately after the first treatment session, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Expected outcome 4: Improvement in medial longitudinal arch mobility was expected, as assessed using the Navicular Drop Test, by comparing assessments performed before the intervention, immediately after the first treatment session, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Observed outcome 4	—

Measure

Time frame

Expected outcome 3: Improvement in ankle dorsiflexion range of motion in a weight-bearing position was expected, as assessed using the Weight-Bearing Lunge Test with a digital inclinometer (Clinometer® for Android), by comparing assessments performed before the intervention, immediately after the first treatment session, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Observed outcome 3: No significant difference in ankle dorsiflexion range of motion in a weight-bearing position was observed between participants who received myofascial release and the control group, as assessed using the Weight-Bearing Lunge Test with a digital inclinometer (Clinometer® for Android), before the intervention, immediately after the first treatment session, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Expected outcome 2: Improvement in lower limb functional performance was expected, as assessed using the Single-Leg Hop Test, by comparing the single-leg horizontal jump distance, measured in centimeters (cm), before the intervention, immediately after the first treatment session, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Observed outcome 2: No significant difference in lower limb functional performance was observed between participants who received myofascial release and the control group, as assessed using the Single-Leg Hop Test, before the intervention, immediately after the first treatment session, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Expected outcome 4: Improvement in medial longitudinal arch mobility was expected, as assessed using the Navicular Drop Test, by comparing assessments performed before the intervention, immediately after the first treatment session, after four weeks of treatment, and four weeks after completion of the intervention (follow-up).;Observed outcome 4

—

Countries

Contacts

Public ContactSilvia Amado João

Universidade de São Paulo

smaj@usp.br+551130918424

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 9, 2026